Recruiting

Vitamin C

Sponsor:

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Code:

NCT06306183

Conditions

Pain, Acute

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vitamin C

Placebo

Study Details

Brief summary:

Musculoskeletal (MSK) injuries such as sprains, strains, bruises, and fractures are among the most common reasons people visit the emergency department. These injuries often cause significant pain in the first few days, making it difficult to move, work, or sleep. Usual pain medications like ibuprofen or acetaminophen can help, but they are not safe or effective for everyone. Some people cannot take them because of heart, kidney, stomach, or liver problems. Others still experience strong pain despite treatment. Because of these limits, some patients receive opioids, which can cause side effects and carry a risk of dependence. Safer and more accessible options are needed.

Vitamin C is widely known for supporting the immune system, but research suggests it may also help reduce pain and inflammation. Studies in surgical patients have shown that vitamin C can lower pain levels, reduce the need for opioids, and support healing. These effects may be linked to its antioxidant properties and its role in tissue repair. However, no study has tested whether vitamin C can help people with recent MSK injuries treated in the emergency department.

The VICAMED study aims to answer this question. Adults arriving with an MSK injury that occurred within the past 48 hours can participate if they have at least moderate pain. Participants are randomly assigned to receive either vitamin C or a placebo. The first dose is given in the emergency department, followed by twice daily capsules for three days. Pain is measured using a simple 0-100 scale, recorded in an electronic or paper diary. A follow-up on day six helps the research team understand each participant's recovery, medication use, and overall experience.

Vitamin C is inexpensive, widely available, and very safe at the doses used in this study. If it proves effective, it could offer a simple, low risk option to help patients manage pain after an MSK injury and reduce the need for opioids in emergency care.

Conditions

Pain, Acute

Study ID

NCT06306183

Start date

Sep 1, 2025

Status verified date

Feb, 2026

Completion date

Dec, 2029

Anticipated

Primary completion date

Dec, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Age ≥ 18 years old
2. Presenting to the ED with acute MSK pain of ≤ 48 hours duration at triage
3. Verbal numerical rating scale pain intensity at triage of ≥ 4 on a 0-10 scale
4. Triaged to the ambulatory section of the ED
5. Able to communicate in French or English

Exclusion Criteria:

1. Usage of Vit C supplements in the last week
2. Active cancer
3. Treated with opioids for any pain within 24 hours prior to recruitment
4. Treatment for chronic pain
5. Unable to fill out a pain intensity diary or unavailable for follow-up
6. Allergy to milk (lactose in the placebo) or Vit C
7. Treated with cyclosporine or warfarin
8. Pre-existing oxalate nephropathy, liver cirrhosis or hemochromatosis
9. Hospitalized after clinician evaluation

Study Design

Enrollment

204 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Basic Science

Interventions and Outcome Measures

Arms

experimental: Vitamin C

900 mg vitamin C taken orally twice a day

placebo comparator: Placebo

Placebo taken orally twice a day

Interventions

Vitamin C

900 mg vitamin C taken orally twice a day (one in the morning and one in the evening) for a 3-day period after ED discharge for the treatment arm.

Placebo

Placebo taken orally twice a day (one in the morning and one in the evening) for a 3-day period after ED discharge for the treatment arm.

Primary outcome measure

  • Time-weighted sum of the pain-intensity difference (SPID) [ Time Frame: Three days ]

Central Contacts and Locations

Central contacts

Locations

Hopital du Sacre-Coeur de Montreal

Recruiting

Montreal, Quebec, Canada, H4J 1C5

Contacts

More Information

Sponsor

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Last update posted

Mar 2, 2026

Last verified

Feb, 2026

Keywords

  • Vitamin C
  • NSAID
  • Emergency department
  • Pain
  • RCT

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal on 2026-03-02.